Global Pets Anti Infective Medicine Market Growth 2025-2031

December 2025 | 99 pages | ID: G681C2B85A5EN
LP Information

Abstracts

The global Pets Anti Infective Medicine market size is predicted to grow from US$ 1961 million in 2025 to US$ 2816 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Anti-infective medicines for pets are medications used to treat and prevent infections in animals.

These medications kill or inhibit the growth of bacteria. Common types of antibiotics for pets include penicillins, cephalosporins, tetracyclines, and fluoroquinolones.These medications are used to treat viral infections in pets. Examples include acyclovir, famciclovir, and interferon.

These medicines are used to treat and prevent parasites in pets, including fleas, ticks, mites, and worms. Some common antiparasitic medications include ivermectin, milbemycin, fenbendazole, and praziquantel.

LP Information, Inc. (LPI) ' newest research report, the “Pets Anti Infective Medicine Industry Forecast” looks at past sales and reviews total world Pets Anti Infective Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pets Anti Infective Medicine sales for 2025 through 2031. With Pets Anti Infective Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pets Anti Infective Medicine industry.

This Insight Report provides a comprehensive analysis of the global Pets Anti Infective Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pets Anti Infective Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pets Anti Infective Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pets Anti Infective Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pets Anti Infective Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Pets Anti Infective Medicine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• External Use
• Internal Use

Segmentation by Application:

• Dogs
• Cats
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Boehringer Ingelheim
• Zoetis
• Merck
• Elanco
• Bayer
• Virbac
• Ceva Sante Animale
• Vetoquinol
• Bimeda Animal Health
• Chanelle

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pets Anti Infective Medicine market?

What factors are driving Pets Anti Infective Medicine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pets Anti Infective Medicine market opportunities vary by end market size?

How does Pets Anti Infective Medicine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pets Anti Infective Medicine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Pets Anti Infective Medicine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Pets Anti Infective Medicine by Country/Region, 2020, 2024 & 2031
2.2 Pets Anti Infective Medicine Segment by Type
  2.2.1 External Use
  2.2.2 Internal Use
2.3 Pets Anti Infective Medicine Sales by Type
  2.3.1 Global Pets Anti Infective Medicine Sales Market Share by Type (2020-2025)
  2.3.2 Global Pets Anti Infective Medicine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Pets Anti Infective Medicine Sale Price by Type (2020-2025)
2.4 Pets Anti Infective Medicine Segment by Application
  2.4.1 Dogs
  2.4.2 Cats
  2.4.3 Other
2.5 Pets Anti Infective Medicine Sales by Application
  2.5.1 Global Pets Anti Infective Medicine Sale Market Share by Application (2020-2025)
  2.5.2 Global Pets Anti Infective Medicine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Pets Anti Infective Medicine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Pets Anti Infective Medicine Breakdown Data by Company
  3.1.1 Global Pets Anti Infective Medicine Annual Sales by Company (2020-2025)
  3.1.2 Global Pets Anti Infective Medicine Sales Market Share by Company (2020-2025)
3.2 Global Pets Anti Infective Medicine Annual Revenue by Company (2020-2025)
  3.2.1 Global Pets Anti Infective Medicine Revenue by Company (2020-2025)
  3.2.2 Global Pets Anti Infective Medicine Revenue Market Share by Company (2020-2025)
3.3 Global Pets Anti Infective Medicine Sale Price by Company
3.4 Key Manufacturers Pets Anti Infective Medicine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pets Anti Infective Medicine Product Location Distribution
  3.4.2 Players Pets Anti Infective Medicine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PETS ANTI INFECTIVE MEDICINE BY GEOGRAPHIC REGION

4.1 World Historic Pets Anti Infective Medicine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Pets Anti Infective Medicine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Pets Anti Infective Medicine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pets Anti Infective Medicine Market Size by Country/Region (2020-2025)
  4.2.1 Global Pets Anti Infective Medicine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Pets Anti Infective Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pets Anti Infective Medicine Sales Growth
4.4 APAC Pets Anti Infective Medicine Sales Growth
4.5 Europe Pets Anti Infective Medicine Sales Growth
4.6 Middle East & Africa Pets Anti Infective Medicine Sales Growth

5 AMERICAS

5.1 Americas Pets Anti Infective Medicine Sales by Country
  5.1.1 Americas Pets Anti Infective Medicine Sales by Country (2020-2025)
  5.1.2 Americas Pets Anti Infective Medicine Revenue by Country (2020-2025)
5.2 Americas Pets Anti Infective Medicine Sales by Type (2020-2025)
5.3 Americas Pets Anti Infective Medicine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pets Anti Infective Medicine Sales by Region
  6.1.1 APAC Pets Anti Infective Medicine Sales by Region (2020-2025)
  6.1.2 APAC Pets Anti Infective Medicine Revenue by Region (2020-2025)
6.2 APAC Pets Anti Infective Medicine Sales by Type (2020-2025)
6.3 APAC Pets Anti Infective Medicine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pets Anti Infective Medicine by Country
  7.1.1 Europe Pets Anti Infective Medicine Sales by Country (2020-2025)
  7.1.2 Europe Pets Anti Infective Medicine Revenue by Country (2020-2025)
7.2 Europe Pets Anti Infective Medicine Sales by Type (2020-2025)
7.3 Europe Pets Anti Infective Medicine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pets Anti Infective Medicine by Country
  8.1.1 Middle East & Africa Pets Anti Infective Medicine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Pets Anti Infective Medicine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pets Anti Infective Medicine Sales by Type (2020-2025)
8.3 Middle East & Africa Pets Anti Infective Medicine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pets Anti Infective Medicine
10.3 Manufacturing Process Analysis of Pets Anti Infective Medicine
10.4 Industry Chain Structure of Pets Anti Infective Medicine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pets Anti Infective Medicine Distributors
11.3 Pets Anti Infective Medicine Customer

12 WORLD FORECAST REVIEW FOR PETS ANTI INFECTIVE MEDICINE BY GEOGRAPHIC REGION

12.1 Global Pets Anti Infective Medicine Market Size Forecast by Region
  12.1.1 Global Pets Anti Infective Medicine Forecast by Region (2026-2031)
  12.1.2 Global Pets Anti Infective Medicine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pets Anti Infective Medicine Forecast by Type (2026-2031)
12.7 Global Pets Anti Infective Medicine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Boehringer Ingelheim
  13.1.1 Boehringer Ingelheim Company Information
  13.1.2 Boehringer Ingelheim Pets Anti Infective Medicine Product Portfolios and Specifications
  13.1.3 Boehringer Ingelheim Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Boehringer Ingelheim Main Business Overview
  13.1.5 Boehringer Ingelheim Latest Developments
13.2 Zoetis
  13.2.1 Zoetis Company Information
  13.2.2 Zoetis Pets Anti Infective Medicine Product Portfolios and Specifications
  13.2.3 Zoetis Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Zoetis Main Business Overview
  13.2.5 Zoetis Latest Developments
13.3 Merck
  13.3.1 Merck Company Information
  13.3.2 Merck Pets Anti Infective Medicine Product Portfolios and Specifications
  13.3.3 Merck Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Merck Main Business Overview
  13.3.5 Merck Latest Developments
13.4 Elanco
  13.4.1 Elanco Company Information
  13.4.2 Elanco Pets Anti Infective Medicine Product Portfolios and Specifications
  13.4.3 Elanco Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Elanco Main Business Overview
  13.4.5 Elanco Latest Developments
13.5 Bayer
  13.5.1 Bayer Company Information
  13.5.2 Bayer Pets Anti Infective Medicine Product Portfolios and Specifications
  13.5.3 Bayer Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Bayer Main Business Overview
  13.5.5 Bayer Latest Developments
13.6 Virbac
  13.6.1 Virbac Company Information
  13.6.2 Virbac Pets Anti Infective Medicine Product Portfolios and Specifications
  13.6.3 Virbac Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Virbac Main Business Overview
  13.6.5 Virbac Latest Developments
13.7 Ceva Sante Animale
  13.7.1 Ceva Sante Animale Company Information
  13.7.2 Ceva Sante Animale Pets Anti Infective Medicine Product Portfolios and Specifications
  13.7.3 Ceva Sante Animale Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Ceva Sante Animale Main Business Overview
  13.7.5 Ceva Sante Animale Latest Developments
13.8 Vetoquinol
  13.8.1 Vetoquinol Company Information
  13.8.2 Vetoquinol Pets Anti Infective Medicine Product Portfolios and Specifications
  13.8.3 Vetoquinol Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Vetoquinol Main Business Overview
  13.8.5 Vetoquinol Latest Developments
13.9 Bimeda Animal Health
  13.9.1 Bimeda Animal Health Company Information
  13.9.2 Bimeda Animal Health Pets Anti Infective Medicine Product Portfolios and Specifications
  13.9.3 Bimeda Animal Health Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Bimeda Animal Health Main Business Overview
  13.9.5 Bimeda Animal Health Latest Developments
13.10 Chanelle
  13.10.1 Chanelle Company Information
  13.10.2 Chanelle Pets Anti Infective Medicine Product Portfolios and Specifications
  13.10.3 Chanelle Pets Anti Infective Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Chanelle Main Business Overview
  13.10.5 Chanelle Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pets Anti Infective Medicine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pets Anti Infective Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of External Use
Table 4. Major Players of Internal Use
Table 5. Global Pets Anti Infective Medicine Sales by Type (2020-2025) & (K Units)
Table 6. Global Pets Anti Infective Medicine Sales Market Share by Type (2020-2025)
Table 7. Global Pets Anti Infective Medicine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pets Anti Infective Medicine Revenue Market Share by Type (2020-2025)
Table 9. Global Pets Anti Infective Medicine Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Pets Anti Infective Medicine Sale by Application (2020-2025) & (K Units)
Table 11. Global Pets Anti Infective Medicine Sale Market Share by Application (2020-2025)
Table 12. Global Pets Anti Infective Medicine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pets Anti Infective Medicine Revenue Market Share by Application (2020-2025)
Table 14. Global Pets Anti Infective Medicine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pets Anti Infective Medicine Sales by Company (2020-2025) & (K Units)
Table 16. Global Pets Anti Infective Medicine Sales Market Share by Company (2020-2025)
Table 17. Global Pets Anti Infective Medicine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pets Anti Infective Medicine Revenue Market Share by Company (2020-2025)
Table 19. Global Pets Anti Infective Medicine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pets Anti Infective Medicine Producing Area Distribution and Sales Area
Table 21. Players Pets Anti Infective Medicine Products Offered
Table 22. Pets Anti Infective Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pets Anti Infective Medicine Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Pets Anti Infective Medicine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pets Anti Infective Medicine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pets Anti Infective Medicine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pets Anti Infective Medicine Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Pets Anti Infective Medicine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pets Anti Infective Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pets Anti Infective Medicine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pets Anti Infective Medicine Sales by Country (2020-2025) & (K Units)
Table 34. Americas Pets Anti Infective Medicine Sales Market Share by Country (2020-2025)
Table 35. Americas Pets Anti Infective Medicine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pets Anti Infective Medicine Sales by Type (2020-2025) & (K Units)
Table 37. Americas Pets Anti Infective Medicine Sales by Application (2020-2025) & (K Units)
Table 38. APAC Pets Anti Infective Medicine Sales by Region (2020-2025) & (K Units)
Table 39. APAC Pets Anti Infective Medicine Sales Market Share by Region (2020-2025)
Table 40. APAC Pets Anti Infective Medicine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pets Anti Infective Medicine Sales by Type (2020-2025) & (K Units)
Table 42. APAC Pets Anti Infective Medicine Sales by Application (2020-2025) & (K Units)
Table 43. Europe Pets Anti Infective Medicine Sales by Country (2020-2025) & (K Units)
Table 44. Europe Pets Anti Infective Medicine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pets Anti Infective Medicine Sales by Type (2020-2025) & (K Units)
Table 46. Europe Pets Anti Infective Medicine Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Pets Anti Infective Medicine Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Pets Anti Infective Medicine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pets Anti Infective Medicine Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Pets Anti Infective Medicine Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pets Anti Infective Medicine
Table 52. Key Market Challenges & Risks of Pets Anti Infective Medicine
Table 53. Key Industry Trends of Pets Anti Infective Medicine
Table 54. Pets Anti Infective Medicine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pets Anti Infective Medicine Distributors List
Table 57. Pets Anti Infective Medicine Customer List
Table 58. Global Pets Anti Infective Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Pets Anti Infective Medicine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pets Anti Infective Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Pets Anti Infective Medicine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pets Anti Infective Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Pets Anti Infective Medicine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pets Anti Infective Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Pets Anti Infective Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pets Anti Infective Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Pets Anti Infective Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pets Anti Infective Medicine Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Pets Anti Infective Medicine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pets Anti Infective Medicine Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Pets Anti Infective Medicine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Pets Anti Infective Medicine Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. Zoetis Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 78. Zoetis Pets Anti Infective Medicine Product Portfolios and Specifications
Table 79. Zoetis Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Zoetis Main Business
Table 81. Zoetis Latest Developments
Table 82. Merck Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Pets Anti Infective Medicine Product Portfolios and Specifications
Table 84. Merck Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Elanco Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Pets Anti Infective Medicine Product Portfolios and Specifications
Table 89. Elanco Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Elanco Main Business
Table 91. Elanco Latest Developments
Table 92. Bayer Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Pets Anti Infective Medicine Product Portfolios and Specifications
Table 94. Bayer Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. Virbac Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 98. Virbac Pets Anti Infective Medicine Product Portfolios and Specifications
Table 99. Virbac Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Virbac Main Business
Table 101. Virbac Latest Developments
Table 102. Ceva Sante Animale Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Sante Animale Pets Anti Infective Medicine Product Portfolios and Specifications
Table 104. Ceva Sante Animale Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Ceva Sante Animale Main Business
Table 106. Ceva Sante Animale Latest Developments
Table 107. Vetoquinol Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 108. Vetoquinol Pets Anti Infective Medicine Product Portfolios and Specifications
Table 109. Vetoquinol Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Vetoquinol Main Business
Table 111. Vetoquinol Latest Developments
Table 112. Bimeda Animal Health Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 113. Bimeda Animal Health Pets Anti Infective Medicine Product Portfolios and Specifications
Table 114. Bimeda Animal Health Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Bimeda Animal Health Main Business
Table 116. Bimeda Animal Health Latest Developments
Table 117. Chanelle Basic Information, Pets Anti Infective Medicine Manufacturing Base, Sales Area and Its Competitors
Table 118. Chanelle Pets Anti Infective Medicine Product Portfolios and Specifications
Table 119. Chanelle Pets Anti Infective Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Chanelle Main Business
Table 121. Chanelle Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pets Anti Infective Medicine
Figure 2. Pets Anti Infective Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pets Anti Infective Medicine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pets Anti Infective Medicine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pets Anti Infective Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pets Anti Infective Medicine Sales Market Share by Country/Region (2024)
Figure 10. Pets Anti Infective Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of External Use
Figure 12. Product Picture of Internal Use
Figure 13. Global Pets Anti Infective Medicine Sales Market Share by Type in 2025
Figure 14. Global Pets Anti Infective Medicine Revenue Market Share by Type (2020-2025)
Figure 15. Pets Anti Infective Medicine Consumed in Dogs
Figure 16. Global Pets Anti Infective Medicine Market: Dogs (2020-2025) & (K Units)
Figure 17. Pets Anti Infective Medicine Consumed in Cats
Figure 18. Global Pets Anti Infective Medicine Market: Cats (2020-2025) & (K Units)
Figure 19. Pets Anti Infective Medicine Consumed in Other
Figure 20. Global Pets Anti Infective Medicine Market: Other (2020-2025) & (K Units)
Figure 21. Global Pets Anti Infective Medicine Sale Market Share by Application (2024)
Figure 22. Global Pets Anti Infective Medicine Revenue Market Share by Application in 2025
Figure 23. Pets Anti Infective Medicine Sales by Company in 2025 (K Units)
Figure 24. Global Pets Anti Infective Medicine Sales Market Share by Company in 2025
Figure 25. Pets Anti Infective Medicine Revenue by Company in 2025 ($ millions)
Figure 26. Global Pets Anti Infective Medicine Revenue Market Share by Company in 2025
Figure 27. Global Pets Anti Infective Medicine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Pets Anti Infective Medicine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Pets Anti Infective Medicine Sales 2020-2025 (K Units)
Figure 30. Americas Pets Anti Infective Medicine Revenue 2020-2025 ($ millions)
Figure 31. APAC Pets Anti Infective Medicine Sales 2020-2025 (K Units)
Figure 32. APAC Pets Anti Infective Medicine Revenue 2020-2025 ($ millions)
Figure 33. Europe Pets Anti Infective Medicine Sales 2020-2025 (K Units)
Figure 34. Europe Pets Anti Infective Medicine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Pets Anti Infective Medicine Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Pets Anti Infective Medicine Revenue 2020-2025 ($ millions)
Figure 37. Americas Pets Anti Infective Medicine Sales Market Share by Country in 2025
Figure 38. Americas Pets Anti Infective Medicine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Pets Anti Infective Medicine Sales Market Share by Type (2020-2025)
Figure 40. Americas Pets Anti Infective Medicine Sales Market Share by Application (2020-2025)
Figure 41. United States Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Pets Anti Infective Medicine Sales Market Share by Region in 2025
Figure 46. APAC Pets Anti Infective Medicine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Pets Anti Infective Medicine Sales Market Share by Type (2020-2025)
Figure 48. APAC Pets Anti Infective Medicine Sales Market Share by Application (2020-2025)
Figure 49. China Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Pets Anti Infective Medicine Sales Market Share by Country in 2025
Figure 57. Europe Pets Anti Infective Medicine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Pets Anti Infective Medicine Sales Market Share by Type (2020-2025)
Figure 59. Europe Pets Anti Infective Medicine Sales Market Share by Application (2020-2025)
Figure 60. Germany Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Pets Anti Infective Medicine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Pets Anti Infective Medicine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Pets Anti Infective Medicine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Pets Anti Infective Medicine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pets Anti Infective Medicine in 2025
Figure 74. Manufacturing Process Analysis of Pets Anti Infective Medicine
Figure 75. Industry Chain Structure of Pets Anti Infective Medicine
Figure 76. Channels of Distribution
Figure 77. Global Pets Anti Infective Medicine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Pets Anti Infective Medicine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Pets Anti Infective Medicine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Pets Anti Infective Medicine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Pets Anti Infective Medicine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Pets Anti Infective Medicine Revenue Market Share Forecast by Application (2026-2031)